|
Forward Ventures aims to provide significant returns to investors by investing
in companies that develop and commercialize innovative and effective treatments
for serious diseases.
Forward Ventures takes a hands-on, team approach to developing its
portfolio companies. The partners apply their networks and business, startup,
scientific and medical expertise to build the value of their portfolio
companies. Forward Ventures also provides additional capital, syndication
with other leading life science venture investors and access to the investment
banking firms that understand the needs of emerging biotech companies.
|
 |
|
|
| 3/21/2007 | | EISAI To Aquire Morphotek | | Morphotek Press Release | | more | | 3/5/2007 | | Lilly announces acquisition of Hypnion | | Hypnion Press Release | | more | | 1/11/2007 | | Dr. Ivor Royston talked about his career and his transition from research scientist to entrepreneur and then venture capitalist on I’m There for You Baby: The Entrepreneur’s Guide to the Galaxy. | | The Entrepreneur’s Guide to the Galaxy | | more |
|
|
|
| 7/25/2007 | | Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipline of Cardiovascular Drug Candidates | | NovaCardia Press Release | | more | | 7/12/2007 | | TargeGen, Inc. Closes $40M Series “D” Financing Round | | Targegen Press Release | | more | | 5/29/2007 | | Avalon Pharmaceuticals Closes $20 Million in Private Placement of Common Stock and Warrants to Institutional Investors | | Avalon Press Release | | more | | 5/9/2007 | | TargeGen Receives 2007 James D. Watson Helix Award | | TargeGen Press Release | | more | | 5/9/2007 | | Avalon Pharmaceuticals Reports First Quarter 2007 Results | | Avalon Press Release | | more |
|
|
|
|
 |